I. Dykukha

Systematic reviews of randomized controlled trials of cannabinoid products in chronic pain conditions and for symptoms associated with multiple sclerosis: what do they tell us?

C. Vaney, C. Vila Silván, I. Dykukha, 2022, Expert review of clinical pharmacology.

Effects of Sativex® on cognitive function in patients with multiple sclerosis: A systematic review and meta-analysis.

I. Penner, H. Schreiber, I. Dykukha, 2022, Multiple sclerosis and related disorders.

Nabiximols in chronic neuropathic pain: a meta-analysis of randomized placebo-controlled trials.

R. Malessa, M. Überall, I. Dykukha, 2021, Pain medicine.

Comparative Efficacy and Safety of Tirbanibulin for Actinic Keratosis of the Face and Scalp in Europe: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

S. Graziadio, M. Heppt, M. Edwards, 2022, Journal of clinical medicine.

Application of the Statistical Method to Convert Published PASI 50/75/90/100 into Absolute PASI Response Rate in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab Based on Data from the Two Pivotal Phase 3 Studies reSURFACE 1 and reSURFACE 2

R. Vonthein, U. Mrowietz, I. Kasujee, 2022, Dermatology.

Individuals at risk for severe COVID-19 in whom ritonavir-containing therapies are contraindicated or may lead to interactions with concomitant medications: a retrospective analysis of German health insurance claims data

S. Melnik, I. Dykukha, Nina Gruber, 2023, Drugs in context.